Functional Glycomics homepage


The synthetic glycans listed below are available in the CFG Reagent Bank. Investigators may request these reagents in order to confirm ligands identified by glycan array screening at the Protein-Glycan Interaction Core, further assess lectin-ligand specificity and affinity, inhibit protein-glycan interactions, perform co-crystallization studies, and more. Most of these reagents were produced by the CFG's Glycan Array Synthesis Core (D) during its period of operation from 2001-2011, and will remain available until stocks are depleted. To cover the cost of distributing reagents, investigators will be requested to pay a $250.00 handling fee plus shipping costs for each resource request. A request can include more than one reagent.

Compound No. Saccharide Name and Type of Synthetic Spacer Common Name Quantities1
M5 GlcNAcb-Sp GN 1 mg, 5 mg

Compound No. Saccharide Name and Type of Synthetic Spacer Common Name Quantities1
D11 Galb1-3GalNAca-Thr TF 1 mg
D8 Galb1-3GlcNAcb-Sp Lec 1 mg, 5 mg
D9 Galb1-4Glcb-Sp Lac, L 1 mg
D10 Galb1-4GlcNAcb-Sp LacNAc, LN 1 mg
D14 Neu5Aca2-6GalNAca-Thr STn 1 mg

Compound No. Saccharide Name and Type of Synthetic Spacer Common Name Quantities1
Tr116 Fuca1-2Galb1-3GlcNAcb-Sp H-type1 1 mg, 5 mg
Tr120 Fuca1-2Galb1-4Glcb-Sp 2'FL 1 mg, 5 mg
Tr117 Fuca1-2Galb1-4GlcNAcb-Sp H-type2 1 mg, 5 mg
Tr260 Gala1-3Galb1-3GlcNAcb-Sp Gala3-type1 1 mg
Tr59 Gala1-3Galb1-4Glcb-Sp Galili-tri 1 mg, 5 mg
Tr60 Gala1-3Galb1-4GlcNAcb-Sp B2-tri 1 mg
Tr61 Gala1-4Galb1-4Glcb-Sp Pk 1 mg, 5 mg
Tr62 Gala1-4Galb1-4GlcNAcb-Sp P1 tri 1 mg, 5 mg
Tr57 Galb1-3[Fuca1-4]GlcNAcb-Sp LeA 1 mg, 5 mg
Tr38 Galb1-3[Neu5Aca2-6]GalNAca-Thr 6'STF 1 mg, 5 mg
Tr58 Galb1-4[Fuca1-3]GlcNAcb-Sp Lex 1 mg, 5 mg
Tr307 GlcNAcb1-3Galb1-3GlcNAcb-Sp 3'GN type1 1 mg
Tr55 GlcNAcb1-3Galb1-4GlcNAcb-Sp GNLN 1 mg, 5 mg
Tr54 GlcNAcb1-3Galb1-4Glcb-Sp LNT-2 1 mg, 5 mg
Tr48 KDNa2-3Galb1-3GlcNAcb-Sp 3'-KDNLec 1 mg, 5 mg
Tr47 KDNa2-3Galb1-4GlcNAcb-Sp 3'KDNLN 1 mg, 5 mg
Tr34 Neu5Aca2-3Galb1-3GlcNAcb-Sp 3'SLec 1 mg, 5 mg
Tr113 Neu5Aca2-3Galb1-4Glc GM3 (no spacer) 1 mg, 5 mg
Tr32 Neu5Aca2-3Galb1-4Glcb-Sp GM3 1 mg, 5 mg
Tr33 Neu5Aca2-3Galb1-4GlcNAcb-Sp 3'SLN 1 mg, 5 mg
Tr35 Neu5Aca2-6Galb1-4Glcb-Sp 6'SL 1 mg, 5 mg
Tr36 Neu5Aca2-6Galb1-4GlcNAcb-Sp 6'SLN 1 mg
Tr269 Neu5Aca2-6GalNAcb1-4GlcNAcb-Sp 6'SLDN 1 mg, 5 mg
Tr323 Neu5Ac(9Ac)a2-3Galb1-3GlcNAcb-Sp 9OAc3'Slec 1 mg
Tr322 Neu5Ac(9Ac)a2-3Galb1-4GlcNAcb-Sp 9OAc3'SLN 1 mg
Tr41 Neu5Gca2-3Galb1-3GlcNAcb-Sp 3'SLec (Gc) 1 mg
Tr39 Neu5Gca2-3Galb1-4Glcb-Sp 3'SL (Gc) 1 mg
Tr40 Neu5Gca2-3Galb1-4GlcNAcb-Sp 3'SLN (Gc) 1 mg
Tr43 Neu5Gca2-6Galb1-4GlcNAcb-Sp 6'SLN (Gc) 1 mg

Tetrasaccharides and Higher
Compound No. Saccharide Name and Type of Synthetic Spacer Common Name Quantities1
Te134 Fuca1-2(Galb1-4GlcNAcb1-3)2b-Sp H2 1 mg, 5 mg
Te118 Fuca1-2Galb1-4[Fuca1-3]GlcNAcb-Sp Ley 1 mg, 5 mg
Te212 Fuca1-2Galb1-4[Fuca1-3]GlcNAcb1-3Galb1-4[Fuca1-3]GlcNAcb-Sp Ley -Lex 1 mg, 5 mg
Te267 Fuca1-2Galb1-4[Fuca1-3]GlcNAcb1-3(Galb1-4[Fuca1-3]GlcNAcb1-3)2b-Sp Ley-Di-Lex 1 mg
Te135 Fuca1-2(Galb1-4GlcNAcb1-3)3b -Sp H3 1 mg
Te258 Gala1-3[Fuca1-2]Galb1-3GlcNAcb-Sp B tetra type 1 1 mg
Te262 Gala1-3[Fuca1-2]Galb1-4[Fuca1-3]GlcNAcb-Sp 2'F-B type 2 1 mg
Te225 Gala1-3[Fuca1-2]Galb1-4Glcb-Sp B tetra L 1 mg
Te223 Gala1-3[Fuca1-2]Galb1-4GlcNAcb-Sp B tetra type 2 1 mg
Te221 Gala1-3Galb1-4[Fuca1-3]GlcNAcb-Sp Gala3Lex 1 mg
Te327 Gala1-4Galb1-4GlcNAcb1-3Galb1-4Glcb-Sp P1 penta 1 mg
Te287 Galb1-3[Fuca1-4]GlcNAcb1-3Galb1-4[Fuca1-3]GlcNAcb-Sp LeALex 1 mg
Te318 Galb1-3[Fuca1-4]GlcNAcb1-3Galb1-3[Fuca1-4]GlcNAcb-Sp Di-LeA 1 mg
Te286 Galb1-3GlcNacb1-3Galb1-4[Fuca1-3]GlcNac-bSp Lec-LeX 1 mg
Te302 Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcNAcb-Sp P1 penta 1 mg
Te271 Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-Sp LNT 1 mg
Te316 Galb1-3GlcNAcb1-3Galb1-3GlcNAcb-Sp Di-Lec 1 mg
Te101 (Galb1-4[Fuca1-3]GlcNAcb1-3)2b-Sp Di-Lex 1 mg
Te102 (Galb1-4[Fuca1-3]GlcNAcb1-3)3b-Sp Tri-Lex 1 mg
Te319 Galb1-4[Fuca1-3]GlcNAcb1-3Galb1-3[Fuca1-4]GlcNAcb-Sp Lex-LeA 1 mg
Te98 (Galb1-4GlcNAcb1-3)2b-Sp Di-LN 1 mg, 5 mg
Te100 (Galb1-4GlcNAcb1-3)3b-Sp Tri-LN 1 mg, 5 mg
Te72 Galb1-4GlcNAcb1-3Galb1-4Glcb-Sp LNnT 1 mg, 5 mg
Te259 GalNAca1-3[Fuca1-2]Galb1-3GlcNAcb-Sp A tetra type 1 1 mg
Te261 GalNAca1-3[Fuca1-2]Galb1-4[Fuca1-3]GlcNAcb-Sp 2'F-A type 2 1 mg
Te224 GalNAca1-3[Fuca1-2]Galb1-4Glcb-Sp A tetra L 1 mg, 5 mg
Te222 GalNAca1-3[Fuca1-2]Galb1-4GlcNAcb-Sp A tetra type 2 1 mg
Te289 GalNAcb1-3Gala1-4Galb1-4GlcNAcb-Sp P1 tetra 1 mg
Te99 GlcNAcb1-3(Galb1-4GlcNAcb1-3)2b-Sp 3'GN-Di-LN 1 mg
Te325 Neu5Aca2-3(Galb1-3[Fuca1-4]GlcNAcb1-3)2b-Sp 3'S-Di-LeA 1 mg
Te304 Neu5Aca2-3Galb1-3[Fuca1-4]GlcNAcb1-3Galb1-4[Fuca1-3]GlcNAcb-Sp 3'SLeA-LeX 1 mg
Te291 Neu5Aca2-3Galb1-3GalNAcb1-3Gala1-4Galb1-4Glcb-Sp SSEA-4 1 mg
Te321 Neu5Aca2-3Galb1-3GlcNAcb1-3Galb1-3GlcNAcb-Sp 3'S-Di-Lec 1 mg
Te288 Neu5Aca2-3Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-Sp 3'SLecLN 1 mg
Te75 Neu5Aca2-3[Galb1-3GalNAcb1-4]Galb1-4Glcb-Sp GM1 1 mg
Te64 Neu5Aca2-3Galb1-4[Fuca1-3]GlcNAcb-Sp 3'SLex 1 mg, 5 mg
Te140 Neu5Aca2-3(Galb1-4[Fuca1-3]GlcNAcb1-3)2b-Sp 3'S-Di-Lex 1 mg
Te175 Neu5Aca2-3[Galb1-4GlcNAcb1-3)2b-Sp 3'S-Di-LN 1 mg, 5 mg
Te192 Neu5Aca2-3[Galb1-4GlcNAcb1-3)3b-Sp 3'STri-LN 1 mg
Te320 Neu5Aca2-3Galb1-4GlcNAcb1-3Galb1-3GlcNAcb-Sp 3'SLN-Lec 1 mg
Te74 Neu5Aca2-3[GalNAcb1-4]Galb1-4Glcb-Sp GM2 1 mg
Te201 Neu5Aca2-3[GalNAcb1-4]Galb1-4GlcNAcb-Sp CT/Sda 1 mg
Te303 Neu5Aca2-3[Neu5Aca2-3Galb1-3GalNAcb1-4]Galb1-4Glcb-Sp GD1a 1 mg
Te176 Neu5Aca2-6[Galb1-4GlcNAcb1-3)2b-Sp 6'S-Di-LN 1 mg, 5 mg
Te324 Neu5Aca2-6Galb1-4GlcNAcb1-3Galb1-3GlcNAcb-Sp 6SLN-Lec 1 mg
Te78 Neu5Aca2-8Neu5Aca2-3[GalNAcb1-4]Galb1-4Glcb-Sp GD2 1 mg
Te79 Neu5Aca2-8Neu5Aca2-3Galb1-4Glcb-Sp GD3 1 mg, 5 mg
Te97 Neu5Aca2-8Neu5Aca2-8Neu5Aca2-3Galb1-4Glcb-Sp GT3 1 mg
Te119 Neu5Aca2-8Neu5Aca2-8Neu5Aca2-3[GalNAcb1-4]Galb1-4Glcb-Sp GT2 1 mg
Te306 Neu5Aca2-8Neu5Aca2-8Neu5Aca2-8Neu5Aca2-3[GalNAcb1-4]Galb1-4Glcb-Sp GQ2 1 mg

Glycolipid Quantity
a-Galactosyl ceramide (aGalCer) 25 micrograms in 25 microliters

1 Requests for larger amounts must include a detailed justification in the resource request.

Request Resources

More Information

Methods and Data

Last Updated Tuesday, 26-Mar-2013 11:39:38 EDT. Please contact us with comments/questions.